Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
Status:
Completed
Trial end date:
2000-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption
and crime-related post-traumatic stress disorder in those individuals with both disorders.
This will be a 12-week, placebo-controlled, double-blind outpatient trial.
All subjects will receive cognitive behavioral therapy in addition to a placebo or
sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and
6, 9, and 12 months after study entry.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)